Physician profile
Martha A Pearson
NPI 1962418491
$682.65
in general payments reported to CMS, 2019-2025
8 companies · $96.33 in 2025
The $96.33 reported for 2025 was less than what a typical Psychiatric/Mental Health, Child & Adolescent (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $315).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $178 · 2023: $113 · 2024: $95.96 · 2025: $96.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $462.69 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $58.09 | 2023-2025 | Spravato, Invega |
| Otsuka America Pharmaceutical, INC. | $58.03 | 2024-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.02 | 2024-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $19.52 | 2024 | Ingrezza |
| Glaxosmithkline, LLC. | $17.37 | 2024 | Arexvy, Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $14.76 | 2025 | Cobenfy |
| Alkermes, INC. | $14.17 | 2023 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.